MTM(SH:688029) Sou Hu Cai Jing·2025-08-14 13:32Group 1 - The core viewpoint of the articles highlights the performance and valuation of Nanwei Medical, which has a current stock price of 94.95 yuan and a rolling PE ratio of 29.43 times, significantly lower than the industry average of 55.76 times [1][2] - As of June 30, 2025, the number of shareholders in Nanwei Medical decreased to 12,345, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares [1] - The company specializes in the research, manufacturing, and sales of minimally invasive medical devices, with key products including endoscopic diagnostic instruments and microwave/radiofrequency ablation equipment [1] Group 2 - In the latest half-year report for 2025, Nanwei Medical achieved a revenue of 1.565 billion yuan, representing a year-on-year growth of 17.36%, and a net profit of 363 million yuan, also reflecting a year-on-year increase of 17.04% [1] - The gross profit margin for the company stands at 64.89%, indicating a strong profitability relative to its revenue [1] - The industry average PE ratio is 55.76, while the median is 39.14, positioning Nanwei Medical at the 58th rank within the medical device sector [2]